Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)

v3.22.0.1
Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Research and Development Expense [Member]    
Share-based payment arrangement, expense $ 1,276 $ 290
General and Administrative Expense [Member]    
Share-based payment arrangement, expense $ 1,078 $ 696